Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Review Article

Mouse Models of Familial Hemiplegic Migraine for Studying Migraine Pathophysiology

Author(s): Anisa Dehghani and Hulya Karatas*

Volume 17, Issue 10, 2019

Page: [961 - 973] Pages: 13

DOI: 10.2174/1570159X17666190513085013

Price: $65

conference banner
Abstract

Migraine, an extremely disabling neurological disorder, has a strong genetic component. Since monogenic migraines (resulting from mutations or changes in a single gene) may help researchers discover migraine pathophysiology, transgenic mice models harboring gene mutations identified in Familial Hemiplegic Migraine (FHM) patients have been generated. Studies in these FHM mutant mice models have shed light on the mechanisms of migraine and may aid in the identification of novel targets for treatment. More specifically, the studies shed light on how gene mutations, hormones, and other factors impact the pathophysiology of migraine. The models may also be of relevance to researchers outside the field of migraine as some of their aspects are relevant to pain in general. Additionally, because of the comorbidities associated with migraine, they share similarities with the mutant mouse models of epilepsy, stroke, and perhaps depression. Here, we review the experimental data obtained from these mutant mice and focus on how they can be used to investigate the pathophysiology of migraine, including synaptic plasticity, neuroinflammation, metabolite alterations, and molecular and behavioral mechanisms of pain.

Keywords: Familial hemiplegic migraine, mouse models, migraine with aura, cortical spreading depression, pathophysiology, neuroinflammation, treatment.

Graphical Abstract
[1]
Vos, T.; Flaxman, A.D.; Naghavi, M.; Lozano, R.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.A.; Abdalla, S.; Aboyans, V.; Abraham, J.; Ackerman, I.; Aggarwal, R.; Ahn, S.Y.; Ali, M.K.; Alvarado, M.; Anderson, H.R.; Anderson, L.M.; Andrews, K.G.; Atkinson, C.; Baddour, L.M.; Bahalim, A.N.; Barker-Collo, S.; Barrero, L.H.; Bartels, D.H.; Basáñez, M.G.; Baxter, A.; Bell, M.L.; Benjamin, E.J.; Bennett, D.; Bernabé, E.; Bhalla, K.; Bhandari, B.; Bikbov, B.; Bin Abdulhak, A.; Birbeck, G.; Black, J.A.; Blencowe, H.; Blore, J.D.; Blyth, F.; Bolliger, I.; Bonaventure, A.; Boufous, S.; Bourne, R.; Boussinesq, M.; Braithwaite, T.; Brayne, C.; Bridgett, L.; Brooker, S.; Brooks, P.; Brugha, T.S.; Bryan-Hancock, C.; Bucello, C.; Buchbinder, R.; Buckle, G.; Budke, C.M.; Burch, M.; Burney, P.; Burstein, R.; Calabria, B.; Campbell, B.; Canter, C.E.; Carabin, H.; Carapetis, J.; Carmona, L.; Cella, C.; Charlson, F.; Chen, H.; Cheng, A.T.; Chou, D.; Chugh, S.S.; Coffeng, L.E.; Colan, S.D.; Colquhoun, S.; Colson, K.E.; Condon, J.; Connor, M.D.; Cooper, L.T.; Corriere, M.; Cortinovis, M.; de Vaccaro, K.C.; Couser, W.; Cowie, B.C.; Criqui, M.H.; Cross, M.; Dabhadkar, K.C.; Dahiya, M.; Dahodwala, N.; Damsere-Derry, J.; Danaei, G.; Davis, A.; De Leo, D.; Degenhardt, L.; Dellavalle, R.; Delossantos, A.; Denenberg, J.; Derrett, S.; Des Jarlais, D.C.; Dharmaratne, S.D.; Dherani, M.; Diaz-Torne, C.; Dolk, H.; Dorsey, E.R.; Driscoll, T.; Duber, H.; Ebel, B.; Edmond, K.; Elbaz, A.; Ali, S.E.; Erskine, H.; Erwin, P.J.; Espindola, P.; Ewoigbokhan, S.E.; Farzadfar, F.; Feigin, V.; Felson, D.T.; Ferrari, A.; Ferri, C.P.; Fèvre, E.M.; Finucane, M.M.; Flaxman, S.; Flood, L.; Foreman, K.; Forouzanfar, M.H.; Fowkes, F.G.; Franklin, R.; Fransen, M.; Freeman, M.K.; Gabbe, B.J.; Gabriel, S.E.; Gakidou, E.; Ganatra, H.A.; Garcia, B.; Gaspari, F.; Gillum, R.F.; Gmel, G.; Gosselin, R.; Grainger, R.; Groeger, J.; Guillemin, F.; Gunnell, D.; Gupta, R.; Haagsma, J.; Hagan, H.; Halasa, Y.A.; Hall, W.; Haring, D.; Haro, J.M.; Harrison, J.E.; Havmoeller, R.; Hay, R.J.; Higashi, H.; Hill, C.; Hoen, B.; Hoffman, H.; Hotez, P.J.; Hoy, D.; Huang, J.J.; Ibeanusi, S.E.; Jacobsen, K.H.; James, S.L.; Jarvis, D.; Jasrasaria, R.; Jayaraman, S.; Johns, N.; Jonas, J.B.; Karthikeyan, G.; Kassebaum, N.; Kawakami, N.; Keren, A.; Khoo, J.P.; King, C.H.; Knowlton, L.M.; Kobusingye, O.; Koranteng, A.; Krishnamurthi, R.; Lalloo, R.; Laslett, L.L.; Lathlean, T.; Leasher, J.L.; Lee, Y.Y.; Leigh, J.; Lim, S.S.; Limb, E.; Lin, J.K.; Lipnick, M.; Lipshultz, S.E.; Liu, W.; Loane, M.; Ohno, S.L.; Lyons, R.; Ma, J.; Mabweijano, J.; MacIntyre, M.F.; Malekzadeh, R.; Mallinger, L.; Manivannan, S.; Marcenes, W.; March, L.; Margolis, D.J.; Marks, G.B.; Marks, R.; Matsumori, A.; Matzopoulos, R.; Mayosi, B.M.; McAnulty, J.H.; McDermott, M.M.; McGill, N.; McGrath, J.; Medina-Mora, M.E.; Meltzer, M.; Mensah, G.A.; Merriman, T.R.; Meyer, A.C.; Miglioli, V.; Miller, M.; Miller, T.R.; Mitchell, P.B.; Mocumbi, A.O.; Moffitt, T.E.; Mokdad, A.A.; Monasta, L.; Montico, M.; Moradi-Lakeh, M.; Moran, A.; Morawska, L.; Mori, R.; Murdoch, M.E.; Mwaniki, M.K.; Naidoo, K.; Nair, M.N.; Naldi, L.; Narayan, K.M.; Nelson, P.K.; Nelson, R.G.; Nevitt, M.C.; Newton, C.R.; Nolte, S.; Norman, P.; Norman, R.; O’Donnell, M.; O’Hanlon, S.; Olives, C.; Omer, S.B.; Ortblad, K.; Osborne, R.; Ozgediz, D.; Page, A.; Pahari, B.; Pandian, J.D.; Rivero, A.P.; Patten, S.B.; Pearce, N.; Padilla, R.P.; Perez-Ruiz, F.; Perico, N.; Pesudovs, K.; Phillips, D.; Phillips, M.R.; Pierce, K.; Pion, S.; Polanczyk, G.V.; Polinder, S.; Pope, C.A., III; Popova, S.; Porrini, E.; Pourmalek, F.; Prince, M.; Pullan, R.L.; Ramaiah, K.D.; Ranganathan, D.; Razavi, H.; Regan, M.; Rehm, J.T.; Rein, D.B.; Remuzzi, G.; Richardson, K.; Rivara, F.P.; Roberts, T.; Robinson, C.; De Leòn, F.R.; Ronfani, L.; Room, R.; Rosenfeld, L.C.; Rushton, L.; Sacco, R.L.; Saha, S.; Sampson, U.; Sanchez-Riera, L.; Sanman, E.; Schwebel, D.C.; Scott, J.G.; Segui-Gomez, M.; Shahraz, S.; Shepard, D.S.; Shin, H.; Shivakoti, R.; Singh, D.; Singh, G.M.; Singh, J.A.; Singleton, J.; Sleet, D.A.; Sliwa, K.; Smith, E.; Smith, J.L.; Stapelberg, N.J.; Steer, A.; Steiner, T.; Stolk, W.A.; Stovner, L.J.; Sudfeld, C.; Syed, S.; Tamburlini, G.; Tavakkoli, M.; Taylor, H.R.; Taylor, J.A.; Taylor, W.J.; Thomas, B.; Thomson, W.M.; Thurston, G.D.; Tleyjeh, I.M.; Tonelli, M.; Towbin, J.A.; Truelsen, T.; Tsilimbaris, M.K.; Ubeda, C.; Undurraga, E.A.; van der Werf, M.J.; van Os, J.; Vavilala, M.S.; Venketasubramanian, N.; Wang, M.; Wang, W.; Watt, K.; Weatherall, D.J.; Weinstock, M.A.; Weintraub, R.; Weisskopf, M.G.; Weissman, M.M.; White, R.A.; Whiteford, H.; Wiersma, S.T.; Wilkinson, J.D.; Williams, H.C.; Williams, S.R.; Witt, E.; Wolfe, F.; Woolf, A.D.; Wulf, S.; Yeh, P.H.; Zaidi, A.K.; Zheng, Z.J.; Zonies, D.; Lopez, A.D.; Murray, C.J.; AlMazroa, M.A.; Memish, Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859), 2163-2196.
[http://dx.doi.org/10.1016/S0140-6736(12)61729-2] [PMID: 23245607]
[2]
Olesen, J.; Bes, A.; Kunkel, R.; Lance, J.W.; Nappi, G.; Pfaffenrath, V.; Rose, F.C.; Schoenberg, B.S.; Soyka, D.; Tfelt-Hansen, P.; Welch, K.M.A. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia , 2013; 33, pp. (9)629-808.
[http://dx.doi.org/10.1177/0333102413485658] [PMID: 23771276]
[3]
Kurth, T.; Chabriat, H.; Bousser, M.G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol., 2012, 11(1), 92-100.
[http://dx.doi.org/10.1016/S1474-4422(11)70266-6] [PMID: 22172624]
[4]
Spector, J.T.; Kahn, S.R.; Jones, M.R.; Jayakumar, M.; Dalal, D.; Nazarian, S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am. J. Med., 2010, 123(7), 612-624.
[http://dx.doi.org/10.1016/j.amjmed.2009.12.021] [PMID: 20493462]
[5]
Keezer, M.R.; Bauer, P.R.; Ferrari, M.D.; Sander, J.W. The comorbid relationship between migraine and epilepsy: a systematic review and meta-analysis. Eur. J. Neurol., 2015, 22(7), 1038-1047.
[http://dx.doi.org/10.1111/ene.12612] [PMID: 25495495]
[6]
Bauer, P.R.; Carpay, J.A.; Terwindt, G.M.; Sander, J.W.; Thijs, R.J.; Haan, J.; Visser, G.H. Headache and epilepsy. Curr. Pain Headache Rep., 2013, 17(8), 351.
[http://dx.doi.org/10.1007/s11916-013-0351-x] [PMID: 23801004]
[7]
McWilliams, L.A.; Goodwin, R.D.; Cox, B.J. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain, 2004, 111(1-2), 77-83.
[http://dx.doi.org/10.1016/j.pain.2004.06.002] [PMID: 15327811]
[8]
Ferrari, M.D.; Klever, R.R.; Terwindt, G.M.; Ayata, C.; van den Maagdenberg, A.M. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol., 2015, 14(1), 65-80.
[http://dx.doi.org/10.1016/S1474-4422(14)70220-0] [PMID: 25496898]
[9]
Tolner, E.A.; Houben, T.; Terwindt, G.M.; de Vries, B.; Ferrari, M.D.; van den Maagdenberg, A.M. From migraine genes to mechanisms. Pain, 2015, 156(Suppl. 1), S64-S74.
[http://dx.doi.org/10.1097/01.j.pain.0000460346.00213.16] [PMID: 25789438]
[10]
Bolay, H.; Reuter, U.; Dunn, A.K.; Huang, Z.; Boas, D.A.; Moskowitz, M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med., 2002, 8(2), 136-142.
[http://dx.doi.org/10.1038/nm0202-136] [PMID: 11821897]
[11]
Zhang, X.; Levy, D.; Kainz, V.; Noseda, R.; Jakubowski, M.; Burstein, R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann. Neurol., 2011, 69(5), 855-865.
[http://dx.doi.org/10.1002/ana.22329] [PMID: 21416489]
[12]
Karatas, H.; Erdener, S.E.; Gursoy-Ozdemir, Y.; Lule, S.; Eren-Koçak, E.; Sen, Z.D.; Dalkara, T. Spreading depression triggers headache by activating neuronal Panx1 channels. Science, 2013, 339(6123), 1092-1095.
[http://dx.doi.org/10.1126/science.1231897] [PMID: 23449592]
[13]
Lauritzen, M. Pathophysiology of the migraine aura. The spreading depression theory. Brain, 1994, 117(Pt 1), 199-210.
[http://dx.doi.org/10.1093/brain/117.1.199] [PMID: 7908596]
[14]
Eikermann-Haerter, K.; Yuzawa, I.; Qin, T.; Wang, Y.; Baek, K.; Kim, Y.R.; Hoffmann, U.; Dilekoz, E.; Waeber, C.; Ferrari, M.D.; van den Maagdenberg, A.M.; Moskowitz, M.A.; Ayata, C. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J. Neurosci., 2011, 31(15), 5755-5763.
[http://dx.doi.org/10.1523/JNEUROSCI.5346-10.2011] [PMID: 21490217]
[15]
Wessman, M.; Terwindt, G.M.; Kaunisto, M.A.; Palotie, A.; Ophoff, R.A. Migraine: a complex genetic disorder. Lancet Neurol., 2007, 6(6), 521-532.
[http://dx.doi.org/10.1016/S1474-4422(07)70126-6] [PMID: 17509487]
[16]
Tottene, A.; Conti, R.; Fabbro, A.; Vecchia, D.; Shapovalova, M.; Santello, M.; van den Maagdenberg, A.M.; Ferrari, M.D.; Pietrobon, D. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron, 2009, 61(5), 762-773.
[http://dx.doi.org/10.1016/j.neuron.2009.01.027] [PMID: 19285472]
[17]
Mulleners, W.M.; Chronicle, E.P.; Vredeveld, J.W.; Koehler, P.J. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur. J. Neurol., 2002, 9(1), 35-40.
[http://dx.doi.org/10.1046/j.1468-1331.2002.00334.x] [PMID: 11784374]
[18]
Zhang, X.; Velumian, A.A.; Jones, O.T.; Carlen, P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia, 2000, 41(Suppl. 1), S52-S60.
[http://dx.doi.org/10.1111/j.1528-1157.2000.tb02173.x] [PMID: 10768302]
[19]
van der Kamp, W. MaassenVanDenBrink, A.; Ferrari, M.D.; van Dijk, J.G. Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine. Neurology, 1997, 48(5), 1462-1464.
[http://dx.doi.org/10.1212/WNL.48.5.1462] [PMID: 9153495]
[20]
Brighina, F.; Bolognini, N.; Cosentino, G.; Maccora, S.; Paladino, P.; Baschi, R.; Vallar, G.; Fierro, B. Visual cortex hyperexcitability in migraine in response to sound-induced flash illusions. Neurology, 2015, 84(20), 2057-2061.
[http://dx.doi.org/10.1212/WNL.0000000000001584] [PMID: 25888559]
[21]
Mulleners, W.M.; Chronicle, E.P.; Palmer, J.E.; Koehler, P.J.; Vredeveld, J.W. Visual cortex excitability in migraine with and without aura. Headache, 2001, 41(6), 565-572.
[http://dx.doi.org/10.1046/j.1526-4610.2001.041006565.x] [PMID: 11437892]
[22]
Ophoff, R.A.; Terwindt, G.M.; Vergouwe, M.N.; van Eijk, R.; Oefner, P.J.; Hoffman, S.M.; Lamerdin, J.E.; Mohrenweiser, H.W.; Bulman, D.E.; Ferrari, M.; Haan, J.; Lindhout, D.; van Ommen, G.J.; Hofker, M.H.; Ferrari, M.D.; Frants, R.R. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 1996, 87(3), 543-552.
[http://dx.doi.org/10.1016/S0092-8674(00)81373-2] [PMID: 8898206]
[23]
Catterall, W.A. Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium, 1998, 24(5-6), 307-323.
[http://dx.doi.org/10.1016/S0143-4160(98)90055-0] [PMID: 10091001]
[24]
Tottene, A.; Fellin, T.; Pagnutti, S.; Luvisetto, S.; Striessnig, J.; Fletcher, C.; Pietrobon, D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. USA, 2002, 99(20), 13284-13289.
[http://dx.doi.org/10.1073/pnas.192242399] [PMID: 12235360]
[25]
van den Maagdenberg, A.M.; Pietrobon, D.; Pizzorusso, T.; Kaja, S.; Broos, L.A.; Cesetti, T.; van de Ven, R.C.; Tottene, A.; van der Kaa, J.; Plomp, J.J.; Frants, R.R.A.; Ferrari, M.D.A. Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron, 2004, 41(5), 701-710.
[http://dx.doi.org/10.1016/S0896-6273(04)00085-6] [PMID: 15003170]
[26]
Adams, P.J.; Rungta, R.L.; Garcia, E.; van den Maagdenberg, A.M.; MacVicar, B.A.; Snutch, T.P. Contribution of calcium-dependent facilitation to synaptic plasticity revealed by migraine mutations in the P/Q-type calcium channel. Proc. Natl. Acad. Sci. USA, 2010, 107(43), 18694-18699.
[http://dx.doi.org/10.1073/pnas.1009500107] [PMID: 20937883]
[27]
Pietrobon, D. Calcium channels and migraine. Biochimica et Biophysica Acta (BBA)-. Biomembranes, 2013, 1828(7), 1655-1665.
[http://dx.doi.org/10.1016/j.bbamem.2012.11.012]
[28]
Stam, A.H.; Luijckx, G.J.; Poll-Thé, B.T.; Ginjaar, I.B.; Frants, R.R.; Haan, J.; Ferrari, M.D.; Terwindt, G.M.; van den Maagdenberg, A.M. Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation. J. Neurol. Neurosurg. Psychiatry, 2009, 80(10), 1125-1129.
[http://dx.doi.org/10.1136/jnnp.2009.177279] [PMID: 19520699]
[29]
De Fusco, M.; Marconi, R.; Silvestri, L.; Atorino, L.; Rampoldi, L.; Morgante, L.; Ballabio, A.; Aridon, P.; Casari, G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet., 2003, 33(2), 192-196.
[http://dx.doi.org/10.1038/ng1081] [PMID: 12539047]
[30]
Tavraz, N.N.; Friedrich, T.; Dürr, K.L.; Koenderink, J.B.; Bamberg, E.; Freilinger, T.; Dichgans, M. Diverse functional consequences of mutations in the Na+/K+-ATPase α2-subunit causing familial hemiplegic migraine type 2. J. Biol. Chem., 2008, 283(45), 31097-31106.
[http://dx.doi.org/10.1074/jbc.M802771200] [PMID: 18728015]
[31]
Pisano, T.; Spiller, S.; Mei, D.; Guerrini, R.; Cianchetti, C.; Friedrich, T.; Pruna, D. Functional characterization of a novel C-terminal ATP1A2 mutation causing hemiplegic migraine and epilepsy. Cephalalgia, 2013, 33(16), 1302-1310.
[http://dx.doi.org/10.1177/0333102413495116] [PMID: 23838748]
[32]
Riant, F.; De Fusco, M.; Aridon, P.; Ducros, A.; Ploton, C.; Marchelli, F.; Maciazek, J.; Bousser, M.G.; Casari, G.; Tournier-Lasserve, E. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat., 2005, 26(3), 281-281.
[http://dx.doi.org/10.1002/humu.9361] [PMID: 16088919]
[33]
Vanmolkot, K.R.; Kors, E.E.; Turk, U.; Turkdogan, D.; Keyser, A.; Broos, L.A.; Kia, S.K.; van den Heuvel, J.J.; Black, D.F.; Haan, J.; Frants, R.R.; Barone, V.; Ferrari, M.D.; Casari, G.; Koenderink, J.B.; van den Maagdenberg, A.M. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur. J. Hum. Genet., 2006, 14(5), 555-560.
[http://dx.doi.org/10.1038/sj.ejhg.5201607] [PMID: 16538223]
[34]
Echenne, B.; Ducros, A.; Rivier, F.; Joutel, A.; Humbertclaude, V.; Roubertie, A.; Azaïs, M.; Bousser, M.G.; Tournier-Lasserve, E. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics, 1999, 30(4), 214-217.
[http://dx.doi.org/10.1055/s-2007-973493] [PMID: 10569214]
[35]
Spadaro, M.; Ursu, S.; Lehmann-Horn, F.; Veneziano, L.; Antonini, G.; Giunti, P.; Frontali, M.; Jurkat-Rott, K.A. G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics, 2004, 5(3), 177-185.
[http://dx.doi.org/10.1007/s10048-004-0183-2] [PMID: 15459825]
[36]
Jurkat-Rott, K.; Freilinger, T.; Dreier, J.P.; Herzog, J.; Göbel, H.; Petzold, G.C.; Montagna, P.; Gasser, T.; Lehmann-Horn, F.; Dichgans, M. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology, 2004, 62(10), 1857-1861.
[http://dx.doi.org/10.1212/01.WNL.0000127310.11526.FD] [PMID: 15159495]
[37]
Dichgans, M.; Freilinger, T.; Eckstein, G.; Babini, E.; Lorenz-Depiereux, B.; Biskup, S.; Ferrari, M.D.; Herzog, J.; van den Maagdenberg, A.M.; Pusch, M.; Strom, T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet, 2005, 366(9483), 371-377.
[http://dx.doi.org/10.1016/S0140-6736(05)66786-4] [PMID: 16054936]
[38]
Castro, M.J.; Stam, A.H.; Lemos, C.; de Vries, B.; Vanmolkot, K.R.J.; Barros, J.; Terwindt, G.M.; Frants, R.R.; Sequeiros, J.; Ferrari, M.D.; Pereira-Monteiro, J.M.; van den Maagdenberg, A.M. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. Cephalalgia, 2009, 29(3), 308-313.
[http://dx.doi.org/10.1111/j.1468-2982.2008.01721.x] [PMID: 19220312]
[39]
Vahedi, K.; Depienne, C.; Le Fort, D.; Riant, F.; Chaine, P.; Trouillard, O.; Gaudric, A.; Morris, M.A.; Leguern, E.; Tournier-Lasserve, E.; Bousser, M.G. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology, 2009, 72(13), 1178-1183.
[http://dx.doi.org/10.1212/01.wnl.0000345393.53132.8c] [PMID: 19332696]
[40]
Parihar, R.; Ganesh, S. The SCN1A gene variants and epileptic encephalopathies. J. Hum. Genet., 2013, 58(9), 573-580.
[http://dx.doi.org/10.1038/jhg.2013.77] [PMID: 23884151]
[41]
van den Maagdenberg, A.M.; Pizzorusso, T.; Kaja, S.; Terpolilli, N.; Shapovalova, M.; Hoebeek, F.E.; Barrett, C.F.; Gherardini, L.; van de Ven, R.C.; Todorov, B.; Broos, L.A.; Tottene, A.; Gao, Z.; Fodor, M.; De Zeeuw, C.I.; Frants, R.R.; Plesnila, N.; Plomp, J.J.; Pietrobon, D.; Ferrari, M.D. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann. Neurol., 2010, 67(1), 85-98.
[http://dx.doi.org/10.1002/ana.21815] [PMID: 20186955]
[42]
Eikermann-Haerter, K.; Dileköz, E.; Kudo, C.; Savitz, S.I.; Waeber, C.; Baum, M.J.; Ferrari, M.D.; van den Maagdenberg, A.M.; Moskowitz, M.A.; Ayata, C. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J. Clin. Invest., 2009, 119(1), 99-109.
[PMID: 19104150]
[43]
Eikermann-Haerter, K.; Baum, M.J.; Ferrari, M.D.; van den Maagdenberg, A.M.; Moskowitz, M.A.; Ayata, C. Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann. Neurol., 2009, 66(4), 564-568.
[http://dx.doi.org/10.1002/ana.21779] [PMID: 19847904]
[44]
Eikermann-Haerter, K.; Ayata, C. Cortical spreading depression and migraine. Curr. Neurol. Neurosci. Rep., 2010, 10(3), 167-173.
[http://dx.doi.org/10.1007/s11910-010-0099-1] [PMID: 20425031]
[45]
Vecchia, D.; Tottene, A.; van den Maagdenberg, A.M.; Pietrobon, D. Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice. Neurobiol. Dis., 2014, 69, 225-234.
[http://dx.doi.org/10.1016/j.nbd.2014.05.035] [PMID: 24907493]
[46]
Vecchia, D.; Tottene, A.; van den Maagdenberg, A.M.; Pietrobon, D. Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans. Front. Cell. Neurosci., 2015, 9, 8.
[http://dx.doi.org/10.3389/fncel.2015.00008] [PMID: 25741235]
[47]
Dilekoz, E.; Houben, T.; Eikermann-Haerter, K.; Balkaya, M.; Lenselink, A.M.; Whalen, M.J.; Spijker, S.; Ferrari, M.D.; van den Maagdenberg, A.M.; Ayata, C. Migraine mutations impair hippocampal learning despite enhanced long-term potentiation. J. Neurosci., 2015, 35(8), 3397-3402.
[http://dx.doi.org/10.1523/JNEUROSCI.2630-14.2015] [PMID: 25716839]
[48]
Mathew, R.; Andreou, A.P.; Chami, L.; Bergerot, A.; van den Maagdenberg, A.M.; Ferrari, M.D.; Goadsby, P.J. Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse. Cephalalgia, 2011, 31(13), 1368-1380.
[http://dx.doi.org/10.1177/0333102411418847] [PMID: 21893556]
[49]
Fioretti, B.; Catacuzzeno, L.; Sforna, L.; Gerke-Duncan, M.B.; van den Maagdenberg, A.M.J.M.; Franciolini, F.; Connor, M.; Pietrobon, D. Trigeminal ganglion neuron subtype-specific alterations of Ca(V)2.1 calcium current and excitability in a Cacna1a mouse model of migraine. J. Physiol., 2011, 589(Pt 23), 5879-5895.
[http://dx.doi.org/10.1113/jphysiol.2011.220533] [PMID: 22005682]
[50]
Ceruti, S.; Villa, G.; Fumagalli, M.; Colombo, L.; Magni, G.; Zanardelli, M.; Fabbretti, E.; Verderio, C.; van den Maagdenberg, A.M.; Nistri, A.; Abbracchio, M.P. Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain. J. Neurosci., 2011, 31(10), 3638-3649.
[http://dx.doi.org/10.1523/JNEUROSCI.6440-10.2011] [PMID: 21389219]
[51]
Leo, L.; Gherardini, L.; Barone, V.; De Fusco, M.; Pietrobon, D.; Pizzorusso, T.; Casari, G. Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet., 2011, 7(6)e1002129
[http://dx.doi.org/10.1371/journal.pgen.1002129] [PMID: 21731499]
[52]
Bøttger, P.; Glerup, S.; Gesslein, B.; Illarionova, N.B.; Isaksen, T.J.; Heuck, A.; Clausen, B.H.; Füchtbauer, E.M.; Gramsbergen, J.B.; Gunnarson, E.; Aperia, A.; Lauritzen, M.; Lambertsen, K.L.; Nissen, P.; Lykke-Hartmann, K. Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Sci. Rep., 2016, 6, 22047.
[http://dx.doi.org/10.1038/srep22047] [PMID: 26911348]
[53]
Auffenberg, E.; Hedrich, U.; Lerche, H.; Dichgans, M.; Plesnila, N.; Freilinger, T. A novel mouse model for familial hemiplegic migraine type 3 reveals increased susceptibility for cortical spreading depression. Cephalalgia, 2017, •••, 206-206.
[54]
Eikermann-Haerter, K.; Arbel-Ornath, M.; Yalcin, N.; Yu, E.S.; Kuchibhotla, K.V.; Yuzawa, I.; Hudry, E.; Willard, C.R.; Climov, M.; Keles, F.; Belcher, A.M.; Sengul, B.; Negro, A.; Rosen, I.A.; Arreguin, A.; Ferrari, M.D.; van den Maagdenberg, A.M.; Bacskai, B.J.; Ayata, C. Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice. Ann. Neurol., 2015, 78(2), 193-210.
[http://dx.doi.org/10.1002/ana.24449] [PMID: 26032020]
[55]
Shyti, R.; Eikermann-Haerter, K.; van Heiningen, S.H.; Meijer, O.C.; Ayata, C.; Joëls, M.; Ferrari, M.D.; van den Maagdenberg, A.M.; Tolner, E.A. Stress hormone corticosterone enhances susceptibility to cortical spreading depression in familial hemiplegic migraine type 1 mutant mice. Exp. Neurol., 2015, 263, 214-220.
[http://dx.doi.org/10.1016/j.expneurol.2014.10.015] [PMID: 25447936]
[56]
Klychnikov, O.I.; Li, K.W.; Sidorov, I.A.; Loos, M.; Spijker, S.; Broos, L.A.; Frants, R.R.; Ferrari, M.D.; Mayboroda, O.A.; Deelder, A.M.; Smit, A.B.; van den Maagdenberg, A.M. Quantitative cortical synapse proteomics of a transgenic migraine mouse model with mutated Ca(V)2.1 calcium channels. Proteomics, 2010, 10(13), 2531-2535.
[http://dx.doi.org/10.1002/pmic.200900733] [PMID: 20391530]
[57]
Di Guilmi, M.N.; Wang, T.; Inchauspe, C.G.; Forsythe, I.D.; Ferrari, M.D.; van den Maagdenberg, A.M.; Borst, J.G.G.; Uchitel, O.D. Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i. J. Neurosci., 2014, 34(21), 7047-7058.
[http://dx.doi.org/10.1523/JNEUROSCI.2526-13.2014] [PMID: 24849341]
[58]
Inchauspe, C.G.; Urbano, F.J.; Di Guilmi, M.N.; Ferrari, M.D.; van den Maagdenberg, A.M.; Forsythe, I.D.; Uchitel, O.D. Presynaptic CaV2.1 calcium channels carrying familial hemiplegic migraine mutation R192Q allow faster recovery from synaptic depression in mouse calyx of Held. J. Neurophysiol., 2012, 108(11), 2967-2976.
[http://dx.doi.org/10.1152/jn.01183.2011] [PMID: 22956801]
[59]
Inchauspe, C.G.; Urbano, F.J.; Di Guilmi, M.N.; Forsythe, I.D.; Ferrari, M.D.; van den Maagdenberg, A.M.; Uchitel, O.D. Gain of function in FHM-1 Cav2.1 knock-in mice is related to the shape of the action potential. J. Neurophysiol., 2010, 104(1), 291-299.
[http://dx.doi.org/10.1152/jn.00034.2010] [PMID: 20484531]
[60]
Shu, Y.; Hasenstaub, A.; McCormick, D.A. Turning on and off recurrent balanced cortical activity. Nature, 2003, 423(6937), 288-293.
[http://dx.doi.org/10.1038/nature01616] [PMID: 12748642]
[61]
Khennouf, L.; Gesslein, B.; Lind, B.L.; van den Maagdenberg, A.M.; Lauritzen, M. Activity-dependent calcium, oxygen, and vascular responses in a mouse model of familial hemiplegic migraine type 1. Ann. Neurol., 2016, 80(2), 219-232.
[http://dx.doi.org/10.1002/ana.24707] [PMID: 27314908]
[62]
Hullugundi, S.K.; Ansuini, A.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Nistri, A. A hyperexcitability phenotype in mouse trigeminal sensory neurons expressing the R192Q Cacna1a missense mutation of familial hemiplegic migraine type-1. Neuroscience, 2014, 266, 244-254.
[http://dx.doi.org/10.1016/j.neuroscience.2014.02.020] [PMID: 24583041]
[63]
Franceschini, A.; Vilotti, S.; Ferrari, M.D.; van den Maagdenberg, A.M.; Nistri, A.; Fabbretti, E. TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS One, 2013, 8(1)e52394
[http://dx.doi.org/10.1371/journal.pone.0052394] [PMID: 23326332]
[64]
Eising, E.; Shyti, R.; ’t Hoen, P.A.C.; Vijfhuizen, L.S.; Huisman, S.M.H.; Broos, L.A.M.; Mahfouz, A.; Reinders, M.J.T.; Ferrari, M.D.; Tolner, E.A.; de Vries, B.; van den Maagdenberg, A.M.J.M.P.; Vijfhuizen, L.S.; Huisman, S.M.; Broos, L.A.; Mahfouz, A.; Reinders, M.J.; Ferrari, M.D.; Tolner, E.A.; de Vries, B. Cortical spreading depression causes unique dysregulation of inflammatory pathways in a transgenic mouse model of migraine. Mol. Neurobiol., 2017, 54(4), 2986-2996.
[http://dx.doi.org/10.1007/s12035-015-9681-5] [PMID: 27032388]
[65]
Wang, I.M.; Zhang, B.; Yang, X.; Zhu, J.; Stepaniants, S.; Zhang, C.; Meng, Q.; Peters, M.; He, Y.; Ni, C.; Slipetz, D.; Crackower, M.A.; Houshyar, H.; Tan, C.M.; Asante-Appiah, E.; O’Neill, G.; Luo, M.J.; Thieringer, R.; Yuan, J.; Chiu, C.S.; Lum, P.Y.; Lamb, J.; Boie, Y.; Wilkinson, H.A.; Schadt, E.E.; Dai, H.; Roberts, C. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol. Syst. Biol., 2012, 8(1), 594.
[http://dx.doi.org/10.1038/msb.2012.24] [PMID: 22806142]
[66]
Vezzani, A.; French, J.; Bartfai, T.; Baram, T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol., 2011, 7(1), 31-40.
[http://dx.doi.org/10.1038/nrneurol.2010.178] [PMID: 21135885]
[67]
Vezzani, A.; Friedman, A.; Dingledine, R.J. The role of inflammation in epileptogenesis. Neuropharmacology, 2013, 69, 16-24.
[http://dx.doi.org/10.1016/j.neuropharm.2012.04.004] [PMID: 22521336]
[68]
Nair, A.; Simonetti, M.; Birsa, N.; Ferrari, M.D.; van den Maagdenberg, A.M.; Giniatullin, R.; Nistri, A.; Fabbretti, E. Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain. Mol. Pain, 2010, 6(1), 48.
[PMID: 20735819]
[69]
Franceschini, A.; Hullugundi, S.K.; van den Maagdenberg, A.M.; Nistri, A.; Fabbretti, E. Effects of LPS on P2X3 receptors of trigeminal sensory neurons and macrophages from mice expressing the R192Q Cacna1a gene mutation of familial hemiplegic migraine-1. Purinergic Signal., 2013, 9(1), 7-13.
[http://dx.doi.org/10.1007/s11302-012-9328-1] [PMID: 22836594]
[70]
Franceschini, A.; Nair, A.; Bele, T.; van den Maagdenberg, A.M.; Nistri, A.; Fabbretti, E. Functional crosstalk in culture between macrophages and trigeminal sensory neurons of a mouse genetic model of migraine. BMC Neurosci., 2012, 13(1), 143.
[http://dx.doi.org/10.1186/1471-2202-13-143] [PMID: 23171280]
[71]
Dehghani, M.A. Parenchymal Neuroinflammation in Familial Hemiplegic Migraine Type 1 Transgenic Mouse Model After Cortical Spreading Depression. PhD Thesis, Hacettepe University,. 2019.
[72]
Dehghani, A.; Karatas, H.; Can, A.; Erdemli, E.; Yemisci, M.; Eren-Kocak, E.; Dalkara, T. Nuclear expansion and pore opening are instant signs of neuronal hypoxia and can identify poorly fixed brains. Sci. Rep., 2018, 8(1), 14770.
[http://dx.doi.org/10.1038/s41598-018-32878-1] [PMID: 30282977]
[73]
Shyti, R.; Kohler, I.; Schoenmaker, B.; Derks, R.J.; Ferrari, M.D.; Tolner, E.A.; Mayboroda, O.A.; van den Maagdenberg, A.M. Plasma metabolic profiling after cortical spreading depression in a transgenic mouse model of hemiplegic migraine by capillary electrophoresis--mass spectrometry. Mol. Biosyst., 2015, 11(5), 1462-1471.
[http://dx.doi.org/10.1039/C5MB00049A] [PMID: 25856790]
[74]
Carreira, R.J.; Shyti, R.; Balluff, B.; Abdelmoula, W.M.; van Heiningen, S.H.; van Zeijl, R.J.; Dijkstra, J.; Ferrari, M.D.; Tolner, E.A.; McDonnell, L.A.; van den Maagdenberg, A.M. Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine. J. Am. Soc. Mass Spectrom., 2015, 26(6), 853-861.
[http://dx.doi.org/10.1007/s13361-015-1136-8] [PMID: 25877011]
[75]
Xiao, Y.; Richter, J.A.; Hurley, J.H. Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling. Mol. Pain, 2008, 4(1), 12.
[http://dx.doi.org/10.1186/1744-8069-4-12] [PMID: 18416824]
[76]
Shields, K.G.; Storer, R.J.; Akerman, S.; Goadsby, P.J. Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat. Neuroscience, 2005, 135(1), 203-212.
[http://dx.doi.org/10.1016/j.neuroscience.2004.08.054] [PMID: 16084658]
[77]
Eroli, F.; Vilotti, S.; van den Maagdenberg, A.M.J.M.; Nistri, A. Hyperpolarization-activated current Ih in mouse trigeminal sensory neurons in a transgenic mouse model of familial hemiplegic migraine type-1. Neuroscience, 2017, 351, 47-64.
[http://dx.doi.org/10.1016/j.neuroscience.2017.03.033] [PMID: 28363781]
[78]
Hullugundi, S.K.; Ferrari, M.D.; van den Maagdenberg, A.M.; Nistri, A. The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1). PLoS One, 2013, 8(4)e60677
[http://dx.doi.org/10.1371/journal.pone.0060677] [PMID: 23577145]
[79]
Meents, J.E.; Neeb, L.; Reuter, U. TRPV1 in migraine pathophysiology. Trends Mol. Med., 2010, 16(4), 153-159.
[http://dx.doi.org/10.1016/j.molmed.2010.02.004] [PMID: 20347391]
[80]
Zhang, X.C.; Kainz, V.; Burstein, R.; Levy, D. Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain, 2011, 152(1), 140-149.
[http://dx.doi.org/10.1016/j.pain.2010.10.002] [PMID: 21036476]
[81]
Marchenkova, A.; van den Maagdenberg, A.M.; Nistri, A. Loss of inhibition by brain natriuretic peptide over P2X3 receptors contributes to enhanced spike firing of trigeminal ganglion neurons in a mouse model of familial hemiplegic migraine type-1. Neuroscience, 2016, 331, 197-205.
[http://dx.doi.org/10.1016/j.neuroscience.2016.06.034] [PMID: 27346147]
[82]
Vilotti, S.; Vana, N.; Van den Maagdenberg, A.M.; Nistri, A. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice. Neurosci. Lett., 2016, 620, 104-110.
[http://dx.doi.org/10.1016/j.neulet.2016.03.046] [PMID: 27021026]
[83]
Park, J.; Moon, H.; Akerman, S.; Holland, P.R.; Lasalandra, M.P.; Andreou, A.P.; Ferrari, M.D.; van den Maagdenberg, A.M.; Goadsby, P.J. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study. Neurobiol. Dis., 2014, 64, 1-7.
[http://dx.doi.org/10.1016/j.nbd.2013.12.004] [PMID: 24355314]
[84]
Langford, D.J.; Bailey, A.L.; Chanda, M.L.; Clarke, S.E.; Drummond, T.E.; Echols, S.; Glick, S.; Ingrao, J.; Klassen-Ross, T.; Lacroix-Fralish, M.L.; Matsumiya, L.; Sorge, R.E.; Sotocinal, S.G.; Tabaka, J.M.; Wong, D.; van den Maagdenberg, A.M.; Ferrari, M.D.; Craig, K.D.; Mogil, J.S. Coding of facial expressions of pain in the laboratory mouse. Nat. Methods, 2010, 7(6), 447-449.
[http://dx.doi.org/10.1038/nmeth.1455] [PMID: 20453868]
[85]
Chanda, M.L.; Tuttle, A.H.; Baran, I.; Atlin, C.; Guindi, D.; Hathaway, G.; Israelian, N.; Levenstadt, J.; Low, D.; Macrae, L.; O’Shea, L.; Silver, A.; Zendegui, E.; Mariette Lenselink, A.; Spijker, S.; Ferrari, M.D.; van den Maagdenberg, A.M.; Mogil, J.S. Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice. Pain, 2013, 154(8), 1254-1262.
[http://dx.doi.org/10.1016/j.pain.2013.03.038] [PMID: 23673147]
[86]
Wrobel Goldberg, S.; Silberstein, S.D. Targeting CGRP: A new era for migraine treatment. CNS Drugs, 2015, 29(6), 443-452.
[http://dx.doi.org/10.1007/s40263-015-0253-z] [PMID: 26138383]
[87]
Russo, A.F. CGRP as a neuropeptide in migraine: lessons from mice. Br. J. Clin. Pharmacol., 2015, 80(3), 403-414.
[http://dx.doi.org/10.1111/bcp.12686] [PMID: 26032833]
[88]
Recober, A.; Kuburas, A.; Zhang, Z.; Wemmie, J.A.; Anderson, M.G.; Russo, A.F. Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J. Neurosci., 2009, 29(27), 8798-8804.
[http://dx.doi.org/10.1523/JNEUROSCI.1727-09.2009] [PMID: 19587287]
[89]
Recober, A.; Kaiser, E.A.; Kuburas, A.; Russo, A.F. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology, 2010, 58(1), 156-165.
[http://dx.doi.org/10.1016/j.neuropharm.2009.07.009] [PMID: 19607849]
[90]
Deboer, T.; van Diepen, H.C.; Ferrari, M.D.; Van den Maagdenberg, A.M.; Meijer, J.H. Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice. Sleep (Basel), 2013, 36(1), 127-136.
[http://dx.doi.org/10.5665/sleep.2316] [PMID: 23288979]
[91]
de Vries, B.; Eising, E.; Broos, L.A.; Koelewijn, S.C.; Todorov, B.; Frants, R.R.; Boer, J.M.; Ferrari, M.D.; Hoen, P.A.; van den Maagdenberg, A.M. RNA expression profiling in brains of familial hemiplegic migraine type 1 knock-in mice. Cephalalgia, 2014, 34(3), 174-182.
[http://dx.doi.org/10.1177/0333102413502736] [PMID: 23985897]
[92]
Kurth, T.; Chabriat, H.; Bousser, M.G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol., 2012, 11(1), 92-100.
[http://dx.doi.org/10.1016/S1474-4422(11)70266-6] [PMID: 22172624]
[93]
Sacco, S.; Ornello, R.; Ripa, P.; Pistoia, F.; Carolei, A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke, 2013, 44(11), 3032-3038.
[http://dx.doi.org/10.1161/STROKEAHA.113.002465] [PMID: 24085027]
[94]
Spector, J.T.; Kahn, S.R.; Jones, M.R.; Jayakumar, M.; Dalal, D.; Nazarian, S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am. J. Med., 2010, 123(7), 612-624.
[http://dx.doi.org/10.1016/j.amjmed.2009.12.021] [PMID: 20493462]
[95]
Malik, R.; Freilinger, T.; Winsvold, B.S.; Anttila, V.; Vander Heiden, J.; Traylor, M.; de Vries, B.; Holliday, E.G.; Terwindt, G.M.; Sturm, J.; Bis, J.C.; Hopewell, J.C.; Ferrari, M.D.; Rannikmae, K.; Wessman, M.; Kallela, M.; Kubisch, C.; Fornage, M.; Meschia, J.F.; Lehtimäki, T.; Sudlow, C.; Clarke, R.; Chasman, D.I.; Mitchell, B.D.; Maguire, J.; Kaprio, J.; Farrall, M.; Raitakari, O.T.; Kurth, T.; Ikram, M.A.; Reiner, A.P.; Longstreth, W.T., Jr; Rothwell, P.M.; Strachan, D.P.; Sharma, P.; Seshadri, S.; Quaye, L.; Cherkas, L.; Schürks, M.; Rosand, J.; Ligthart, L.; Boncoraglio, G.B.; Davey Smith, G.; van Duijn, C.M.; Stefansson, K.; Worrall, B.B.; Nyholt, D.R.; Markus, H.S.; van den Maagdenberg, A.M.; Cotsapas, C.; Zwart, J.A.; Palotie, A.; Dichgans, M. International Headache Genetics Consortium. METASTROKE Collaboration of the International Stroke Genetics Consortium. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology, 2015, 84(21), 2132-2145.
[http://dx.doi.org/10.1212/WNL.0000000000001606] [PMID: 25934857]
[96]
Eikermann-Haerter, K. Spreading depolarization may link migraine and stroke. Headache, 2014, 54(7), 1146-1157.
[http://dx.doi.org/10.1111/head.12386] [PMID: 24913618]
[97]
Eikermann-Haerter, K.; Lee, J.H.; Yuzawa, I.; Liu, C.H.; Zhou, Z.; Shin, H.K.; Zheng, Y.; Qin, T.; Kurth, T.; Waeber, C.; Ferrari, M.D.; van den Maagdenberg, A.M.; Moskowitz, M.A.; Ayata, C. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation, 2012, 125(2), 335-345.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.045096] [PMID: 22144569]
[98]
Eikermann-Haerter, K.; Lee, J.H.; Yalcin, N.; Yu, E.S.; Daneshmand, A.; Wei, Y.; Zheng, Y.; Can, A.; Sengul, B.; Ferrari, M.D.; van den Maagdenberg, A.M.; Ayata, C. Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. Stroke, 2015, 46(1), 229-236.
[http://dx.doi.org/10.1161/STROKEAHA.114.006982] [PMID: 25424478]
[99]
James, P.F.; Grupp, I.L.; Grupp, G.; Woo, A.L.; Askew, G.R.; Croyle, M.L.; Walsh, R.A.; Lingrel, J.B. Identification of a specific role for the Na, K-ATPase α2 isoform as a regulator of calcium in the heart. Mol. Cell, 1999,3(5), 555-563. Ikeda, K.; Onaka, T.; Yamakado, M.; Nakai, J.; Ishikawa, T.O.; Taketo, M.M. and Kawakami, K., Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump α2 subunit (Atp1a2)-deficient mice. J. Neurosci., 2003, 23(11), 4667-4676.
[PMID: 12805306]
[100]
Ikeda, K.; Onaka, T.; Yamakado, M.; Nakai, J.; Ishikawa, T.O.; Taketo, M.M.; Kawakami, K. Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump α2 subunit (Atp1a2)-deficient mice. J. Neurosci., 2003, 23(11), 4667-4676.
[101]
D’Ambrosio, R.; Gordon, D.S.; Winn, H.R. Differential role of KIR channel and Na(+)/K(+)-pump in the regulation of extracellular K(+) in rat hippocampus. J. Neurophysiol., 2002, 87(1), 87-102.
[http://dx.doi.org/10.1152/jn.00240.2001] [PMID: 11784732]
[102]
Larsen, B.R.; MacAulay, N. Kir4.1-mediated spatial buffering of K(+): experimental challenges in determination of its temporal and quantitative contribution to K(+) clearance in the brain. Channels (Austin), 2014, 8(6), 544-550.
[http://dx.doi.org/10.4161/19336950.2014.970448] [PMID: 25483287]
[103]
Capuani, C.; Melone, M.; Tottene, A.; Bragina, L.; Crivellaro, G.; Santello, M.; Casari, G.; Conti, F.; Pietrobon, D. Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2. EMBO Mol. Med., 2016, 8(8), 967-986.
[http://dx.doi.org/10.15252/emmm.201505944] [PMID: 27354390]
[104]
Karner, E.; Delazer, M.; Benke, T.; Bösch, S. Cognitive functions, emotional behavior, and quality of life in familial hemiplegic migraine. Cogn. Behav. Neurol., 2010, 23(2), 106-111.
[http://dx.doi.org/10.1097/WNN.0b013e3181c3a8a6] [PMID: 20535059]
[105]
Bøttger, P.; Doğanlı, C.; Lykke-Hartmann, K. Migraine- and dystonia-related disease-mutations of Na+/K+-ATPases: relevance of behavioral studies in mice to disease symptoms and neurological manifestations in humans. Neurosci. Biobehav. Rev., 2012, 36(2), 855-871.
[http://dx.doi.org/10.1016/j.neubiorev.2011.10.005] [PMID: 22067897]
[106]
Eikermann-Haerter, K.; Yuzawa, I.; Dilekoz, E.; Joutel, A.; Moskowitz, M.A.; Ayata, C. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann. Neurol., 2011, 69(2), 413-418.
[http://dx.doi.org/10.1002/ana.22281] [PMID: 21387384]
[107]
Hasan, M.; Fermaintt, C.S.; Gao, N.; Sakai, T.; Miyazaki, T.; Jiang, S.; Li, Q.Z.; Atkinson, J.P.; Morse, H.C., III; Lehrman, M.A.; Yan, N. Lehrman, M.A. and Yan, N. Cytosolic nuclease TREX1 regulates oligosaccharyltransferase activity independent of nuclease activity to suppress immune activation. Immunity, 2015, 43(3), 463-474.
[http://dx.doi.org/10.1016/j.immuni.2015.07.022] [PMID: 26320659]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy